Literature DB >> 14616433

Different effects of simvastatin and pravastatin on adrenal sensitivity to angiotensin II.

Koh-Ichi Sugimoto, Akio Fujimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14616433      PMCID： PMC1884309          DOI： 10.1046/j.1365-2125.2003.01929.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Control of aldosterone secretion.

Authors:  J C Chan
Journal:  Nephron       Date:  1979       Impact factor: 2.847

2.  Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.

Authors:  H Ide; S Fujiya; Y Aanuma; Y Agishi
Journal:  Clin Ther       Date:  1990 Sep-Oct       Impact factor: 3.393

3.  A non-chromatographic non-extraction radioimmunoassay for serum aldosterone.

Authors:  T Ogihara; K Iinuma; K Nishi; Y Arakawa; A Takagi
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

4.  Transient symptomatic hypotension in patients on simvastatin.

Authors:  J French; H White
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

5.  [A method for radioimmunoassay of plasma angiotensin II using florisil].

Authors:  T Morimoto; M Aoyama; E Gotoh; H Shionoiri
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1983-03-20

6.  Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.

Authors:  T Koga; T Kikuchi; A Miyazaki; H Koike
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

7.  Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.

Authors:  T J McKenna; S J Sequeira; A Heffernan; J Chambers; S Cunningham
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.